A Phase I/II Trial of CT1190B in Patients With Relapsed/Refractory Large B-Cell Lymphoma
A Phase I/II Trial of CT1190B in Patients With Relapsed/Refractory Large B-Cell Lymphoma
Recruiting · NCT07823829 · Registry updated 2026-10-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/II Trial of CT1190B in Patients With Relapsed/Refractory Large B-Cell Lymphoma | Large B-Cell Lymphoma (LBCL) | Recruiting | Phase 1 / Phase 2 | 2026-10-01 | NCT07823829 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| UCARsgen Biotech Limited | 2 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine | Shanghai | China | 6 |
| Shanghai Tongji Hospital | Shanghai | China | 7 |
| Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology 编辑译文 段落对照 | Hubei | China | 1 |